Taming the inflammasome.
Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
Maayan
M
Levy
Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
Christoph A
CA
Thaiss
Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
Eran
E
Elinav
D020155:3-Hydroxybutyric Acid / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006073:Gout / Q000188:drug therapy; D006801:Humans; D058847:Inflammasomes / Q000037:antagonists & inhibitors*; D007249:Inflammation / Q000188:drug therapy*; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein
D002352:Carrier Proteins; D058847:Inflammasomes; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human; D020155:3-Hydroxybutyric Acid